Quest Diagnostics Incorporated (DGX): The stock had negative money flow to the tune of ($2.01 million) on Thursday, which shows that the traders are selling the stock on the price strength. The inflow of money on upticks was $11.5 million, whereas, the outflow of money on downticks was $13.51 million and the ratio between the two was 0.85. The block trade had a negative net money flow of ($2.06 million). On the other hand, downticks amounted to $2.06 million of the traded value, which shows distribution in the stock by traders. Quest Diagnostics Incorporated (DGX) closed with marginal gains of 6 cents to end the day at $81.25, an increase of 0.07% over the previous days close. The stock recorded 0.01% for the week.
Quest Diagnostics Incorporated (DGX) : The consensus price target for Quest Diagnostics Incorporated (DGX) is $75.58 for the short term with a standard deviation of $3.65. The most optimist securities analyst among the 12 who monitor the stock believes that the stock can reach $84, however, the pessimist price target for the company is $70. The stock has recorded a 20-day Moving Average of 3.64% and the 50-Day Moving Average is 5.52%.
Quest Diagnostics Incorporated (NYSE:DGX): During Thursdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $81.19 and $80.97 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $81.69. The buying momentum continued till the end and the stock did not give up its gains. It closed at $81.23, notching a gain of 0.05% for the day. The total traded volume was 1,170,638 . The stock had closed at $81.19 on the previous day.
Quest Diagnostics Incorporated is a provider of diagnostic testing information services. The Company consists of two businesses: Diagnostic Information Services and Diagnostic Solutions. Diagnostic Information Services business, consists of two parts, develops and delivers diagnostic testing, information and services to patients, physicians, health plans, hospitals, accountable care organizations (ACOs), integrated delivery networks (IDNs), other commercial laboratories, patients and other customers. Diagnostics Information Services business also provides diagnostic information services, which includes providing clinical testing services, such as routine testing, gene-based and esoteric testing, anatomic pathology services and drugs-of-abuse testing. Diagnostic Solutions includes the Companys other businesses, including central laboratory testing for pharmaceutical and medical device clinical trials, risk assessment services, diagnostic products and healthcare information technology.